These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Nusinersen (Spinraza) for spinal muscular atrophy. Med Lett Drugs Ther; 2017 Mar; 59(1517):50-52. PubMed ID: 28323809 [No Abstract] [Full Text] [Related]
7. Gene Therapy, more than ever-a new vision for the journal. Yáñez-Muñoz RJ Gene Ther; 2017 Sep; 24(9):493-494. PubMed ID: 28963565 [No Abstract] [Full Text] [Related]
8. FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides. Aartsma-Rus A Nucleic Acid Ther; 2017 Apr; 27(2):67-69. PubMed ID: 28346110 [No Abstract] [Full Text] [Related]
9. [Can you patent the sun?]. Slørdal L Tidsskr Nor Laegeforen; 2018 Apr; 138(7):. PubMed ID: 29663751 [No Abstract] [Full Text] [Related]
10. Spinal muscular atrophy: A modifiable disease emerges. Fitzgerald DA; Abel F; Jones KJ; Farrar MA Paediatr Respir Rev; 2018 Sep; 28():1-2. PubMed ID: 30414816 [No Abstract] [Full Text] [Related]
11. Ethical Challenges Confronted When Providing Nusinersen Treatment for Spinal Muscular Atrophy. Burgart AM; Magnus D; Tabor HK; Paquette ED; Frader J; Glover JJ; Jackson BM; Harrison CH; Urion DK; Graham RJ; Brandsema JF; Feudtner C JAMA Pediatr; 2018 Feb; 172(2):188-192. PubMed ID: 29228163 [TBL] [Abstract][Full Text] [Related]
12. News Feature: Gene therapy successes point to better therapies. Dolgin E Proc Natl Acad Sci U S A; 2019 Nov; 116(48):23866-23870. PubMed ID: 31772140 [No Abstract] [Full Text] [Related]
17. [Mechanisms of action and patentability of therapeutic oligonucleotides]. Crouvezier N; Marie AC; Moumné L Med Sci (Paris); 2023 Feb; 39(2):111-118. PubMed ID: 36799745 [TBL] [Abstract][Full Text] [Related]
18. Pre-Nusinersen Hospitalization Costs of Children With Spinal Muscular Atrophy. Lee M; França UL; Graham RJ; McManus ML Pediatr Neurol; 2019 Mar; 92():3-5. PubMed ID: 30591237 [No Abstract] [Full Text] [Related]
19. Cure SMA and our patient community celebrate the first approved drug for SMA. Glascock J; Lenz M; Hobby K; Jarecki J Gene Ther; 2017 Sep; 24(9):498-500. PubMed ID: 28504658 [TBL] [Abstract][Full Text] [Related]